AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: EVENITY® (Amgen Inc) (evenity.com)
This is a high-authority, low-BS pharmaceutical site that is technically weighed down by repetitive regulatory compliance and marketing boilerplate. It avoids extreme BS by strictly defining its medical mechanism, though it relies heavily on ‘trust theatre’ testimonials to bridge the gap between clinical data and patient appeal.
To reduce the score, replace verbatim repetition of the ‘works two ways’ H3 tags with specific data points from the clinical trials (e.g., percentage of risk reduction). Add ClinicalTrials.gov ID numbers (NCT numbers) directly to the Clinical Trial Results page text to provide a clear proof path. Include specific bone mineral density (BMD) percentage increases in the headings instead of ‘astounding’ or ‘significant’ descriptors. Finally, attach verified Person schema or professional credentials to any patient or expert quotes to bridge the authority gap.
The site demonstrates a mixed information density. While headings like ‘one-of-a-kind treatment’ and ‘astounding results’ contain power words, the body substance is high due to the mandatory inclusion of dense technical and safety data. The Body substance ratio is favorable because it includes specific technical protocols such as the ’12-month protocol’ and specific cell-level mechanisms (bone-building vs. bone-removing activity). However, concept repetition is high; the phrase ‘works two ways by building new bone and helping to slow bone loss’ is repeated verbatim across H2 and H3 tags on multiple pages, including five instances in the crawled data alone.
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
There is zero semantic drift between the homepage signal and sub-page substance. The homepage H1 ‘builds new bone & helps slow bone loss’ is precisely the focus of the ‘How EVENITY Works’ sub-page, which details the anabolic and antiresorptive dual mechanism. The messaging remains consistent across the clinical results page and the homepage, maintaining a singular focus on fracture risk reduction and the 12-month treatment window. Heading hierarchies are logical and support the patient-centric narrative without introducing conflicting services or audiences.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
Trust theatre is present primarily through the use of patient testimonials that lack direct verification. The site shows a review_count of 2-3 across pages with a proof_links_count of 0, meaning ‘astounding’ outcomes are presented without links to the specific clinical trial data or patient case studies in the immediate text. Claims like ‘PROVEN TO SIGNIFICANTLY REDUCE’ and ‘Only FDA-approved treatment that does both’ are bold performance assertions that, while likely true in a regulatory sense, lack direct outbound citations to peer-reviewed journals or ClinicalTrials.gov within the crawled content.
Proof density is anchored by technical specificity rather than external validation links. The site cites the 12-month treatment duration and the dual mechanism of action as evidence of uniqueness, but the ratio of verifiable evidence (raw data) to vague assertions (‘grew a lot of bone’) is low in the consumer-facing text. There are approximately 2-3 specific technical markers (DXA results mentioned, dual mechanism) against 7+ instances of broad marketing repetition.
For a concrete demonstration of how the methodology exposes structural, semantic, and commercial gaps in a real hospitality brand, review a full executive level diagnostic applied to a coastal 4 star resort. View the Connemara Coast Hotel Executive SEO Strategy to see how positioning drift, UX friction, and experience SEO failures are surfaced in practice.
The site exhibits a moderate commodity fingerprint due to strict adherence to pharmaceutical web templates. Common industry jargon such as ‘FDA approved,’ ‘clinically proven,’ and ‘mechanism of action’ appear frequently, alongside cliches like ‘pioneering medical science’ implied in the one-of-a-kind claims. The value proposition is unique to the specific drug molecule (romosozumab) and could not be easily copy-pasted onto a generic competitor like Prolia, though the ‘Patient Resources’ and ‘Contact Us’ sections follow standard boilerplate structures.
The authority is well-established through Amgen’s Organization schema, but there is an expert footprint gap. Testimonials like the quote about completing the 12-month protocol are attributed to individuals without a verifiable digital footprint or Person schema. Technical implementation is strong, with proper Drug and MedicalWebPage schema, though the lack of sameAs links for the ‘Call center representative’ or specific clinical leads creates a minor authority gap in the expertise properties.
The marketing tone is highly optimistic (‘results were astounding’), which creates a minor disconnect with the severe clinical warnings required by the FDA. While the site claims a ‘proven’ track record, it does not demonstrate the specific percentage of risk reduction directly in the H2s or H3s, opting for the vague ‘significantly reduce’ rather than raw data points in the top-level hierarchy. This reliance on the prescribing information PDF to hold all substance while the UI presents marketing summaries is a standard pharma disconnect.
Medical Devices, Pharma & Biotech BS: EVENITY® (Amgen Inc) (evenity.com)
The site is an exact match for the Pharma & Biotech industry, specifically focusing on a prescription-only therapeutic area (postmenopausal osteoporosis). The content is heavily structured around regulatory requirements, including boxed warnings and Important Safety Information (ISI), which is characteristic of the sector.
Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.
“The score of 31 is primarily driven by high repetition (Step 1) and Trust Theatre flags (Step 3) where patient reviews are not linked to external proof. The score remains low overall because the identity is verified through Amgen's schema and the semantic alignment between the homepage and technical sub-pages is nearly perfect.”